Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Footer/navigation updates: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-24T14:55:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page header now shows Revision: v3.3.2, replacing v3.2.0. This is a routine version update and does not change trial data.
    Difference
    0.0%
    Check dated 2025-11-25T14:43:32.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The funding/operating status notice at the top of the page was removed. The rest of the page content remains unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:27:09.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new version entry was added to the record history, indicating an update to the study record. The rest of the page content remains unchanged.
    Difference
    0.0%
    Check dated 2025-10-27T21:04:42.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    8%
    Check dated 2025-10-06T08:18:37.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Update indicates a new software version (v3.1.0) replacing the old v3.0.2; no substantive content, pricing, or availability changes are detected.
    Difference
    0.2%
    Check dated 2025-09-29T04:49:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.